BK Treatment Study

Completed · Phase 4 · Has a placebo group

Conditions studied: BK Viremia

In brief

Our hypothesis is that 30 days of oral levofloxacin (FDA approved antibiotic) in patients with persistent viremia (BK virus found in blood) will impair progress to BK virus induced kidney damage by significantly decreasing or eliminating BK virus in the blood.

Key facts

Study ID
NCT01034176
Run by
Brigham and Women's Hospital
People needed
43
Starts
2009-02-01
Expected to finish
2012-10-01
Last updated by the study team
2017-04-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.